The levels of IgG antibodies against SARS-CoV-2 Spike protein remain stable, or even increase, seven months after infection, according to a follow-up study in a cohort of healthcare workers coordinated by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation, in collaboration with the Hospital Clinic of Barcelona. The results, published in Nature Communications, also support the idea that pre-existing antibodies against common cold coronaviruses could protect against COVID-19.
Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection
August 7, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022